Page last updated: 2024-11-02

oxeladin and Glioma

oxeladin has been researched along with Glioma in 1 studies

oxeladin: RN given refers to parent cpd; structure

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lee, SJ1
Yeom, SY1
Lee, JY1
Park, C1

Other Studies

1 other study available for oxeladin and Glioma

ArticleYear
Application of the antitussive agents oxelaidin and butamirate as anti-glioma agents.
    Scientific reports, 2021, 05-12, Volume: 11, Issue:1

    Topics: Animals; Antineoplastic Agents; Antitussive Agents; Apoptosis; Binding Sites; Cell Line, Tumor; Cell

2021